LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.48 | 771.67 | 8500 | 11685 | 0.7274 | 0.8441 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.48 | 771.67 | 10500 | 11685 | 0.8986 | 0.9462 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.69 | 771.67 | 8557 | 11974 | 0.7146 | 0.8371 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.69 | 771.67 | 10818 | 11974 | 0.9035 | 0.9493 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.92 | 771.67 | 8611 | 12266 | 0.7020 | 0.8303 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.92 | 771.67 | 11079 | 12266 | 0.9032 | 0.9496 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.14 | 771.67 | 8589 | 12592 | 0.6821 | 0.8188 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.14 | 771.67 | 11295 | 12592 | 0.8970 | 0.9467 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.49 | 771.67 | 970 | 867 | 1.1178 | 2.8617 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.49 | 771.67 | 833 | 867 | 0.9600 | 0.5710 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.71 | 771.67 | 1091 | 956 | 1.1408 | 2.0604 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.71 | 771.67 | 890 | 956 | 0.9306 | 0.5854 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.94 | 771.67 | 1190 | 1045 | 1.1386 | 1.6907 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.94 | 771.67 | 974 | 1045 | 0.9320 | 0.7025 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.16 | 771.67 | 1308 | 1138 | 1.1489 | 1.5613 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.16 | 771.67 | 1059 | 1138 | 0.9302 | 0.7579 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.56 | 771.67 | 1468 | 1280 | 1.1463 | 1.4109 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.56 | 771.67 | 1194 | 1280 | 0.9324 | 0.8172 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.78 | 771.67 | 1642 | 1459 | 1.1249 | 1.2729 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 13.78 | 771.67 | 1338 | 1459 | 0.9166 | 0.8193 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.00 | 771.67 | 1790 | 1585 | 1.1290 | 1.2477 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.00 | 771.67 | 1445 | 1585 | 0.9114 | 0.8291 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.22 | 771.67 | 1925 | 1741 | 1.1054 | 1.1783 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.22 | 771.67 | 1577 | 1741 | 0.9056 | 0.8381 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.44 | 771.67 | 2145 | 1910 | 1.1225 | 1.1847 | MN20160304_L01 | I15 |